SAR125844 is primarily investigated for its potential therapeutic applications in cancer treatment, particularly targeting specific types of tumors. It functions as a selective inhibitor of certain kinases involved in cell signaling pathways that promote cancer growth and survival. Research has focused on its efficacy in treating cancers with mutations or dysregulations in these pathways, such as certain forms of lung cancer and other solid tumors. Preclinical studies have shown promising results in inhibiting tumor progression and enhancing the effectiveness of other anticancer therapies. Clinical trials are ongoing to further evaluate its safety, tolerability, and potential as a targeted therapy in oncology.